论文部分内容阅读
目的:探讨双黄连粉针剂治疗小儿支气管肺炎的临床效果。方法:选择我院收治的60例小儿支气管肺炎患者为研究对象,采用随机数字表法随机分为对照组和观察组。对照组采用常规对症支持治疗及雾化吸入庆大霉素+α-糜蛋白酶治疗。观察组在常规对症支持治疗的基础上双黄连粉针剂治疗。比较两组治疗效果及症状消失情况。结果:对照组总有效率为76.6%,观察组总有效率为96.6%。观察组治疗效果显著高于对照组,差异有统计学意义(P<0.05)。观察组退热、咳嗽咳痰消失时间早于对照组,差异有统计学意义(P<0.01)。结论:采用双黄连粉针剂治疗,疗效好,治愈率高,值得临床推广应用。
Objective: To investigate the clinical effect of Shuanghuanglian injection on bronchial pneumonia in children. Methods: Sixty cases of children with bronchopneumonia treated in our hospital were selected as the research object and randomly divided into control group and observation group by random number table. The control group was treated with conventional symptomatic supportive therapy and nebulization of gentamicin + α-chymotrypsin. Observation group on the basis of conventional symptomatic and supportive treatment Shuanghuanglian powder injection treatment. Compare the two groups of treatment effect and the disappearance of symptoms. Results: The total effective rate of the control group was 76.6%, the total effective rate of the observation group was 96.6%. The treatment effect of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Observation group fever, cough and expectoration disappeared earlier than the control group, the difference was statistically significant (P <0.01). Conclusion: Shuanghuanglian powder injection treatment, good curative effect, high cure rate, worthy of clinical application.